Publications by authors named "Bernat Olle"

Claim this Profile
A
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults.
Jeffrey L Silber, Jason M Norman, Tokuwa Kanno, Emily M Crossette, Rose Szabady, Bernat Olle

Eur J Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correspondence to "Escape Velocity-The Launch of Microbiome Therapies".
Bernat Olle, Ryan Ranallo, L Clifford McDonald

J Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Gut microbiota strain richness is species specific and affects engraftment.
Alice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, Craig Haifer, Zhihua Li, Bernat Olle

Nature· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota strain richness is species specific and affects engraftment.
Alice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, Craig Haifer, Zhihua Li, Bernat Olle

Nature· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection.
Rajita Menon, Shakti K Bhattarai, Emily Crossette, Amanda L Prince, Bernat Olle

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commensal consortia decolonize Enterobacteriaceae via ecological control.
Munehiro Furuichi, Takaaki Kawaguchi, Marie-Madlen Pust, Keiko Yasuma-Mitobe, Damian R Plichta, Bernat Olle

Nature· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationally-defined microbial consortia suppress multidrug-resistant proinflammatory Enterobacteriaceae via ecological control.
Kenya Honda, Munehiro Furuichi, Takaaki Kawaguchi, Marie-Madlen Pust, Keiko Yasuma-Mitobe, Bernat Olle

Res Sq· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
Thomas Louie, Yoav Golan, Sahil Khanna, Dmitri Bobilev, Nathalie Erpelding, Bernat Olle

JAMA· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of trypsin-degrading commensals in the large intestine.
Youxian Li, Eiichiro Watanabe, Yusuke Kawashima, Damian R Plichta, Zhujun Wang, Bernat Olle

Nature· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers.
Melissa Dsouza, Rajita Menon, Emily Crossette, Shakti K Bhattarai, Jessica Schneider, Bernat Olle

Cell Host Microbe· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections.
Quinten R Ducarmon, Ed J Kuijper, Bernat Olle

J Infect Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.
Takeshi Tanoue, Satoru Morita, Damian R Plichta, Ashwin N Skelly, Wataru Suda, Bernat Olle

Nature· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating microbiome futures.
Gaspar Taroncher-Oldenburg, Susan Jones, Martin Blaser, Richard Bonneau, Peter Christey, Bernat Olle

Nat Biotechnol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer-guided design of optimal microbial consortia for immune system modulation.
Richard R Stein, Takeshi Tanoue, Rose L Szabady, Shakti K Bhattarai, Bernat Olle

Elife· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US immigration order strikes against biotech.
Jeremy M Levin, Steven H Holtzman, John Maraganore, Paul J Hastings, Ron Cohen, Bernat Olle

Nat Biotechnol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDSINE: Microbial Dynamical Systems INference Engine for microbiome time-series analyses.
Vanni Bucci, Belinda Tzen, Ning Li, Matt Simmons, Takeshi Tanoue, Bernat Olle

Genome Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA's pathway for regulation of FMT: not so fraught.
Margaret F Riley, Bernat Olle

J Law Biosci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Koji Atarashi, Takeshi Tanoue, Kenshiro Oshima, Wataru Suda, Yuji Nagano, Bernat Olle

Nature· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicines from microbiota.
Bernat Olle

Nat Biotechnol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis